Cancer Therapy / Nato ASI Subseries H: Bd.75 (PDF)
Differentiation, Immunomodulation and Angiogenesis
(Sprache: Englisch)
Provided here is a comprehensive examination of the basic
and clinical condition of three innovative and promising
approaches to cancer therapy, which may support or even
substitute chemotherapy: differentiation, immunomodulation,
and inhibition...
and clinical condition of three innovative and promising
approaches to cancer therapy, which may support or even
substitute chemotherapy: differentiation, immunomodulation,
and inhibition...
sofort als Download lieferbar
eBook (pdf)
96.29 €
48 DeutschlandCard Punkte
sammeln
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
Produktdetails
Produktinformationen zu „Cancer Therapy / Nato ASI Subseries H: Bd.75 (PDF)“
Provided here is a comprehensive examination of the basic
and clinical condition of three innovative and promising
approaches to cancer therapy, which may support or even
substitute chemotherapy: differentiation, immunomodulation,
and inhibition of angiogenesis.
Differentiation shouldnormalize neoplastic cells and make
them compatible with the host. Its feasibility with
retinoids, interferons, chemotherapeutic and other agents is
discussed. Modulation by biological agents, cytotoxic
effector cells and drugs is considered in attempts to
boost endogenous antitumour defenses and/or to render
neoplastic cells more susceptible to the immune attack of
the host. Finally, the important aspect of interfering with
tumour blood vessel development and function is taken
into account.
Consideringthe importance that chemotherapy has in cancer
treatment and in view of a more and more integrated
strategy, the relationship between the aforementioned
approaches and chemotherapeutic agents and chemoresistance
is treated in detail.
and clinical condition of three innovative and promising
approaches to cancer therapy, which may support or even
substitute chemotherapy: differentiation, immunomodulation,
and inhibition of angiogenesis.
Differentiation shouldnormalize neoplastic cells and make
them compatible with the host. Its feasibility with
retinoids, interferons, chemotherapeutic and other agents is
discussed. Modulation by biological agents, cytotoxic
effector cells and drugs is considered in attempts to
boost endogenous antitumour defenses and/or to render
neoplastic cells more susceptible to the immune attack of
the host. Finally, the important aspect of interfering with
tumour blood vessel development and function is taken
into account.
Consideringthe importance that chemotherapy has in cancer
treatment and in view of a more and more integrated
strategy, the relationship between the aforementioned
approaches and chemotherapeutic agents and chemoresistance
is treated in detail.
Bibliographische Angaben
- 2013, 1993, 288 Seiten, Englisch
- Herausgegeben: Natale D'Alessandro, Enrico Mihich, Luciano Rausa, Haim Tapiero, Thomas R. Tritton
- Verlag: Springer Berlin Heidelberg
- ISBN-10: 3642846130
- ISBN-13: 9783642846137
- Erscheinungsdatum: 29.06.2013
Abhängig von Bildschirmgröße und eingestellter Schriftgröße kann die Seitenzahl auf Ihrem Lesegerät variieren.
eBook Informationen
- Dateiformat: PDF
- Größe: 23 MB
- Ohne Kopierschutz
- Vorlesefunktion
Sprache:
Englisch
Kommentar zu "Cancer Therapy / Nato ASI Subseries H: Bd.75"
0 Gebrauchte Artikel zu „Cancer Therapy / Nato ASI Subseries H: Bd.75“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Cancer Therapy / Nato ASI Subseries H: Bd.75".
Kommentar verfassen